Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression

C. L. Arteaga, S. D. Hurd, A. R. Winnier, M. D. Johnson, B. M. Fendly, J. T. Forbes

Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration
Simmons Comprehensive Cancer Center

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression

Fingerprint

Medicine & Life Sciences